Texas Register May 17, 2019 Volume: 44 Number: 20

Texas Department of Mental Health and Mental Retardation

 

Proposed Rules

Amendments regarding the Podiatric Medicine Program

The proposed rules implement a change from a one-year license to a two-year license term, provide for a reduction in license fees, and for the orderly transition between the license terms. The Sunset Advisory Commission recommended, along with the transfer of the Podiatric Medicine program from the Texas State Board of Podiatric Medical Examiners, that the Department be authorized to provide biennial license renewals. This brings the Doctor of Podiatric Medicine license term more in line with other similar health-related professions.


Texas Board of Occupational Therapy Examiners

Adopted Rules

Amendments to §369.2, concerning changes of name or address

The amendments are adopted to remove the requirement that an occupational therapy assistant with a regular license notify the Board of supervisor changes and to add language regarding the address of record to the section.In the amendments, a provision concerning the requirement that a licensee or applicant notify the Board of changes of supervisor has been revised. In the current rule, licensees and applicants are required to notify the Board of changes of supervisor within 30 days. In the amendments, this has been revised to require instead that only applicants and temporary licensees notify the Board of changes of supervisor.The repeal of §373.3, concerning supervision of an occupational therapy assistant, has also been adopted and submitted to the Texas Register for publication. The repeal of such will remove the requirement that an occupational therapy assistant with a regular license submit supervisor information on the Occupational Therapy Assistant Supervision form.


Texas Board of Occupational Therapy Examiners

Adopted Rules

Adopts amendments to §372.1, concerning provision of services, and §372.2, concerning general purpose occupation-based instruction

The amendments are adopted to clean up and clarify the sections and to add clarifying language to §372.1, regarding the transmission of a medical referral.Cleanups and clarifications to §372.1 include changes to provisions regarding an occupational therapist’s delegation of the collection of data for an evaluation and the delegation of tasks. In the amendments to such provisions, references to a temporary licensee have been removed as the references to an occupational therapy assistant therein already refer to both an occupational therapy assistant with a regular or temporary license.The amendments also include language clarifying that when a referral is required for the provision of occupational therapy services, such may be transmitted by an occupational therapy plan of care, developed according to the requirements of the section, that is signed by the licensed referral source.The amendments, in addition, include a clarification of a requirement regarding the inclusion of an occupational therapist’s name in the intervention note.The amendments to §372.1 include further cleanups and clarifications.The amendments, additionally, include a change to §372.2 to strike a reference to the supervision requirements in §373.3 because the repeal of §373.3, concerning supervision of an occupational therapy assistant, has also been adopted and submitted to the Texas Register for publication.


Texas Department of State Health Services

In Addition

Order Maintaining butyryl fentanyl and U-47700 in Schedule I; Placing furanyl fentanyl, 4-fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil into Schedule I; and placing MAB-CHMINACA into Schedule I

The Administrator of the Drug Enforcement Administration issued a final order to permanently maintain the substances butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) and U-47700(3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide),including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, into schedule I of the Controlled Substances Act, effective April 20, 2018. This final order was published in the Federal Register, Volume 83, Number 77, pages 17486-17488.